Fenwick & West represented Chapter in the transaction. Chapter, a Medicare navigation platform, announced it has secured $50 million in Series C funding round led by...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Elegen in the transaction. Elegen announced it raised $35 million in Series B Financing Round led by Triatomic Capital and was joined...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Blackwell Security in the transaction. Blackwell Security, a provider of specialized cybersecurity solutions tailored for the healthcare sector, announced its $13 million...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented GoodDay in the deal. GoodDay, developer of a retail operating system designed for Shopify’s ecosystem, announced it has raised $6M in Seed...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Attovia Therapeutics in the transaction. Attovia Therapeutics (“Attovia”), a developer of a pipeline of biotherapeutics with an initial focus on immune-mediated diseases,...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Wiz in the deal. Wiz, developer of an all-in-one cloud security platform, announced it has raised $1 billion in funding. The round co-led...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Rad AI in the transaction. Rad AI announced the closing of its $50 million Series B financing. The round was led by...
You must be a Standard 1 Year member to access this content.
Fenwick & West is representing DocuSign in the transaction. DocuSign (NASDAQ: DOCU) announced it has agreed to acquire Lexion, a provider of AI-powered agreement management software, for...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Pharmakon Advisors in the transaction. Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented CoreWeave in the transaction. CoreWeave announced it has secured $1.1 billion in new funding, led by Coatue, with participation from Magnetar who led the last...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Nominal in the transaction. Nominal, a company specializing in creating end-to-end data analysis solutions for industrial engineering teams, announced its $27.5 million...
You must be a Standard 1 Year member to access this content.
Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte. Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte...
You must be a Standard 1 Year member to access this content.
